TAG:
pathology systems
Pathology, Inc. Sells Equity to Raise Capital
By Robert Michel | From the Volume XVII No. 2 – January 25, 2010 Issue
CEO SUMMARY: In looking how to propel its business to the next level, the partners at Pathology, Inc., opted not to sell their pathology group practice. Instead, they chose to raise capital by selling equity in their company to a group of investors. In this exclusive interview, executives…
Scripps’ Tumor Board Finds Value in Digital Imaging of Slides
By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue
CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase afte…
August 10, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 11 – August 10, 2009 Issue
Last week, the pathology profession got a new professional group. It is the Digital Pathology Association (DPA) and it was formed by several companies offering digital pathology systems and services. DPA’s founders say it will support digital pathology education initiatives, define…
Using Lean at Henry Ford Transforms Pathology TAT
By Robert Michel | From the Volume XVI No. 11 – August 10, 2009 Issue
CEO SUMMARY: Long-standing work flow traditions in anatomic pathology provide fertile ground for improvement with Lean and similar process improvement methods. That was the case at Henry Ford Health System, where empowered teams in the pathology laboratory employed the principles…
April 6, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 5 – April 6, 2009 Issue
Effective May, 1, 2009, Laboratory Corporation of America will no longer be a contract provider for Regence BlueShield, head-quartered in Seattle, Washington. Regence notified physicians that it was ending its relationship with LabCorp “as a result of rising co…
Aperio, Cerner Interface Digital Path and Path LIS
By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue
CEO SUMMARY: For pathologists watching the market acceptance of digital imaging and digital pathology systems, another milestone has been reached. The nation’s largest health IT companies are beginning to develop interfaces between their anatomic pathology laboratory informatio…
January 12, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 1 – January 12, 2009 Issue
Here’s an interesting quirk. It seems none of the major lab professional associations and societies have yet to alert their members to last week’s national news about inaccurate Vitamin D test results at Quest Diagnostics Incorporated. At least, that was true today, based on vis…
Momentum Continues for Digital Pathology
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO SUMMARY: Last month, digital imaging in pathology gained additional momentum with the latest FDA clearance. Aperio Technologies, Inc., now has FDA clearance to market its slide scanning system for reading digital progesterone receptor (PR) slides on a computer monitor. Aperio plans to…
2008’s Top Ten Lab Stories Lacked Disruptive Impact
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO SUMMARY: For the first time in recent memory, a year has passed without major tumult or disruptive change in the laboratory industry. Our list of the Top Ten Most Important Stories of 2008 reflects a rather quiet year when compared to most years of this decade. Howeve…
Siemens, BioImagene, Clarient University of Pennsylvania, Mayo Clinic
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized